{{Rsnum
|rsid=10144042
|Chromosome=14
|position=98033121
|Orientation=plus
|GMAF=0.281
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.5 | 41.6 | 54.9
| HCB | 13.1 | 38.7 | 48.2
| JPT | 16.8 | 47.8 | 35.4
| YRI | 8.8 | 32.7 | 58.5
| ASW | 5.3 | 22.8 | 71.9
| CHB | 13.1 | 38.7 | 48.2
| CHD | 8.3 | 50.5 | 41.3
| GIH | 5.9 | 37.6 | 56.4
| LWK | 3.7 | 35.8 | 60.6
| MEX | 12.3 | 49.1 | 38.6
| MKK | 5.8 | 30.1 | 64.1
| TSI | 5.0 | 32.7 | 62.4
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23118302
  |Trait=Lipoprotein-associated phospholipase A2 activity change in response to statin therapy
  |Title=Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.
  |RiskAllele=A
  |Pval=2E-6
  |OR=1.40
  |ORtxt=[0.62-2.18] percent decrease
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}